Literature DB >> 14984072

Part one: Restoring patients to health outcomes and indicators of advanced nursing practice in adult critical care.

Carol Ball1, Carol L Cox.   

Abstract

The key characteristics of advanced nursing practice have been a subject of international debate over the past decade. To address this debate, a grounded theory study was undertaken by one of the authors which sought to identify the key characteristics of advanced nursing practice in adult critical care. The outcome of the main study was a theory of legitimate influence in which enhancing patient stay and improving patient outcome represented the dual purpose of advanced nursing practice in critical care. Fundamental to these factors is strategic activity. This encompasses improving patient care, facilitating continuity of care and engaging in patient education. The outcome of these strategic activities can be evaluated through evidence of eased transition across complex hospital networks, patient satisfaction and enabling of independence. The findings reflect a change in the focus and delivery of care to the critically ill and their relatives by nurses practising at an advanced level. In the second paper of this series, the intervening conditions that affect the expression of legitimate influence will be discussed.

Entities:  

Mesh:

Year:  2003        PMID: 14984072     DOI: 10.1046/j.1440-172x.2003.00444.x

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  2 in total

1.  Developing radiographer roles in the context of advanced and consultant practice.

Authors:  Lisa J Field; Beverly A Snaith
Journal:  J Med Radiat Sci       Date:  2013-02-05

2.  An exploration of clinical practice in sites with and without clinical nurse or midwife specialists or advanced nurse practitioners, in Ireland.

Authors:  Imelda Coyne; Catherine M Comiskey; Joan G Lalor; Agnes Higgins; Naomi Elliott; Cecily Begley
Journal:  BMC Health Serv Res       Date:  2016-04-26       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.